These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12409737)

  • 1. Metabolic activation of nucleoside and nucleotide reverse transcriptase inhibitors in dendritic and Langerhans cells.
    Balzarini J; Van Herrewege Y; Vanham G
    AIDS; 2002 Nov; 16(16):2159-63. PubMed ID: 12409737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of reverse transcriptase inhibitors in monocyte-derived dendritic cells: a possible in vitro model for postexposure prophylaxis of sexual HIV transmission.
    Van Herrewege Y; Penne L; Vereecken C; Fransen K; van der Groen G; Kestens L; Balzarini J; Vanham G
    AIDS Res Hum Retroviruses; 2002 Oct; 18(15):1091-102. PubMed ID: 12396448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATP-dependent removal of nucleoside reverse transcriptase inhibitors by human immunodeficiency virus type 1 reverse transcriptase.
    Naeger LK; Margot NA; Miller MD
    Antimicrob Agents Chemother; 2002 Jul; 46(7):2179-84. PubMed ID: 12069972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of the anti-HIV activity and metabolic interactions of tenofovir and emtricitabine.
    Borroto-Esoda K; Vela JE; Myrick F; Ray AS; Miller MD
    Antivir Ther; 2006; 11(3):377-84. PubMed ID: 16759055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA.
    Robbins BL; Srinivas RV; Kim C; Bischofberger N; Fridland A
    Antimicrob Agents Chemother; 1998 Mar; 42(3):612-7. PubMed ID: 9517941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of a metabolic and antiviral drug interaction between tenofovir, abacavir and lamivudine.
    Ray AS; Myrick F; Vela JE; Olson LY; Eisenberg EJ; Borroto-Esodo K; Miller MD; Fridland A
    Antivir Ther; 2005; 10(3):451-7. PubMed ID: 15918336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenofovir (PMPA) is less susceptible to pyrophosphorolysis and nucleotide-dependent chain-terminator removal than zidovudine or stavudine.
    Naeger LK; Margot NA; Miller MD
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):635-9. PubMed ID: 11563081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of hydroxyurea on the phosphorylation of zidovudine and lamivudine in human umbilical vein endothelial cells.
    McGuire TR; Hoie EB; Manouilov KK; Gwilt PG
    In Vitro Cell Dev Biol Anim; 2003; 39(7):280-2. PubMed ID: 14572303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals.
    Spaulding A; Rutherford GW; Siegfried N
    Cochrane Database Syst Rev; 2010 Oct; (10):CD008740. PubMed ID: 20927777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 resistance profile of the novel nucleoside reverse transcriptase inhibitor beta-D-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine (Reverset).
    Geleziunas R; Gallagher K; Zhang H; Bacheler L; Garber S; Wu JT; Shi G; Otto MJ; Schinazi RF; Erickson-Viitanen S
    Antivir Chem Chemother; 2003 Jan; 14(1):49-59. PubMed ID: 12790516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenofovir exhibits low cytotoxicity in various human cell types: comparison with other nucleoside reverse transcriptase inhibitors.
    Cihlar T; Birkus G; Greenwalt DE; Hitchcock MJ
    Antiviral Res; 2002 Apr; 54(1):37-45. PubMed ID: 11888656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-steady-state kinetic analysis of the incorporation of anti-HIV nucleotide analogs catalyzed by human X- and Y-family DNA polymerases.
    Brown JA; Pack LR; Fowler JD; Suo Z
    Antimicrob Agents Chemother; 2011 Jan; 55(1):276-83. PubMed ID: 21078938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenofovir, adefovir, and zidovudine susceptibilities of primary human immunodeficiency virus type 1 isolates with non-B subtypes or nucleoside resistance.
    Palmer S; Margot N; Gilbert H; Shaw N; Buckheit R; Miller M
    AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1167-73. PubMed ID: 11522186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenofovir diphosphate is a poor substrate and a weak inhibitor of rat DNA polymerases alpha, delta, and epsilon*.
    Birkus G; Hájek M; Kramata P; Votruba I; Holý A; Otová B
    Antimicrob Agents Chemother; 2002 May; 46(5):1610-3. PubMed ID: 11959615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of nucleoside reverse transcriptase inhibitor pairs in efavirenz-based regimens for treatment-naïve adults with HIV infection in the United States.
    Brogan AJ; Talbird SE; Cohen C
    Value Health; 2011; 14(5):657-64. PubMed ID: 21839403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of human T cell leukemia virus type I to nucleoside reverse transcriptase inhibitors.
    Hill SA; Lloyd PA; McDonald S; Wykoff J; Derse D
    J Infect Dis; 2003 Aug; 188(3):424-7. PubMed ID: 12870124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral activity of tenofovir (PMPA) against nucleoside-resistant clinical HIV samples.
    Miller MD; Margot NA; Hertogs K; Larder B; Miller V
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1025-8. PubMed ID: 11562951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a new cartridge radioimmunoassay for determination of intracellular levels of lamivudine triphosphate in the peripheral blood mononuclear cells of human immunodeficiency virus-infected patients.
    Robbins BL; Tran TT; Pinkerton FH; Akeb F; Guedj R; Grassi J; Lancaster D; Fridland A
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2656-60. PubMed ID: 9756772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamivudine plus tenofovir versus lamivudine plus adefovir for the treatment of hepatitis B virus in HIV-coinfected patients, starting antiretroviral therapy.
    Sarkar J; Saha D; Bandyopadhyay B; Saha B; Chakravarty R; Guha SK
    Indian J Med Microbiol; 2018; 36(2):217-223. PubMed ID: 30084414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transport of lamivudine [(-)-beta-L-2',3'-dideoxy-3'-thiacytidine] and high-affinity interaction of nucleoside reverse transcriptase inhibitors with human organic cation transporters 1, 2, and 3.
    Minuesa G; Volk C; Molina-Arcas M; Gorboulev V; Erkizia I; Arndt P; Clotet B; Pastor-Anglada M; Koepsell H; Martinez-Picado J
    J Pharmacol Exp Ther; 2009 Apr; 329(1):252-61. PubMed ID: 19141712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.